Ethical Challenges to Improving Access to Human Papillomavirus Vaccines in Low- and Middle-Income Countries.
作者信息
Eke Ahizechukwu C, Kerry Vanessa B
机构信息
Division of Maternal-Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore.
Blavatnik Institute of Global Health and Social Medicine, Harvard Medical School, Boston.
出版信息
NEJM Evid. 2022 May;1(5). doi: 10.1056/evide2200069.
Abstract
摘要
相似文献
1
Ethical Challenges to Improving Access to Human Papillomavirus Vaccines in Low- and Middle-Income Countries.
NEJM Evid. 2022 May;1(5). doi: 10.1056/evide2200069.
2
Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects.
Vaccine. 2013 Aug 20;31(37):3811-7. doi: 10.1016/j.vaccine.2013.06.016. Epub 2013 Jun 15.
3
Improving access to affordable vaccines for middle-income countries in the african region.
Vaccine. 2019 May 9;37(21):2838-2842. doi: 10.1016/j.vaccine.2019.03.077. Epub 2019 Apr 9.
4
Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.
Lancet Oncol. 2019 Jul;20(7):915-923. doi: 10.1016/S1470-2045(19)30308-0. Epub 2019 May 28.
5
Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review.
Vaccine. 2013 Aug 20;31(37):3786-804. doi: 10.1016/j.vaccine.2013.06.060. Epub 2013 Jul 3.
6
Single-Dose Human Papillomavirus Vaccination in Low- and Middle-Income Countries-Time for Implementation?
J Pediatr Adolesc Gynecol. 2021 Oct;34(5):586-590. doi: 10.1016/j.jpag.2021.05.006. Epub 2021 Jun 16.
7
University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.
Am J Law Med. 2009;35(2-3):253-79. doi: 10.1177/009885880903500202.
8
Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs.
Int J Gynecol Cancer. 2019 Oct;29(8):1317-1326. doi: 10.1136/ijgc-2019-000582. Epub 2019 Aug 26.
9
Australia's Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific.
Vaccines (Basel). 2021 Aug 18;9(8):921. doi: 10.3390/vaccines9080921.
10
Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries.
BMC Med Ethics. 2022 Mar 9;23(1):21. doi: 10.1186/s12910-022-00764-1.
引用本文的文献
1
Care of Pregnant Women Living with Human Immunodeficiency Virus.
Clin Perinatol. 2024 Dec;51(4):749-767. doi: 10.1016/j.clp.2024.08.010.
本文引用的文献
1
Efficacy of single-dose HPV vaccination among young African women.
NEJM Evid. 2022 Jun;1(5):EVIDoa2100056. doi: 10.1056/EVIDoa2100056. Epub 2022 Apr 11.
2
Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study.
Lancet Oncol. 2021 Nov;22(11):1518-1529. doi: 10.1016/S1470-2045(21)00453-8. Epub 2021 Oct 8.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019.
Prev Med. 2021 Mar;144:106399. doi: 10.1016/j.ypmed.2020.106399. Epub 2020 Dec 31.
5
The nonavalent vaccine: a review of high-risk HPVs and a plea to the CDC.
Am J Stem Cells. 2019 Dec 15;8(3):52-64. eCollection 2019.
6
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.
Lancet Oncol. 2015 Jul;16(7):775-86. doi: 10.1016/S1470-2045(15)00047-9. Epub 2015 Jun 9.
Zotero 插件